Skip to content

    Acumen Pharmaceuticals (ABOS) stock price & financials

    View ABOS earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance+110.1% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    Operating Profit
    -$32.27M
    -$39.60M
    -$30.37M
    -$41.75M
    -$26.51M
    +17.8%
    -$25.20M
    +36.4%
    -$21.15M
    +30.4%
    -$32.56M
    +22.0%
    Strengthening
    Net Profit
    -$29.77M
    -$37.15M
    -$28.80M
    -$40.95M
    -$26.45M
    +11.1%
    -$25.14M
    +32.3%
    -$20.74M
    +28.0%
    -$32.72M
    +20.1%
    Strengthening
    EPS
    $-0.50
    $-0.48
    $-0.68
    $-0.44
    +12.0%
    $-0.33
    +31.2%
    $-0.45
    +33.8%
    Strengthening
    Other Income
    $2.50M
    $2.44M
    $1.57M
    $800.0K
    $62.0K
    -97.5%
    $61.0K
    -97.5%
    $412.0K
    -73.8%
    -$162.0K
    -120.2%
    Weakening
    Interest
    $1.03M
    $1.04M
    $1.02M
    $1.05M
    $1.07M
    +4.0%
    $1.09M
    +4.8%
    $1.07M
    +4.5%
    $1.09M
    +4.6%
    Strengthening
    Depreciation
    Profit before Tax
    MarginsOPM
    Tax
    ReturnsROIC
    5.4%
    6.7%
    5.2%
    7.4%
    4.8%
    -11.1%
    4.6%
    -32.3%
    3.8%
    -28.0%
    5.9%
    -20.1%
    Weakening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$43.78M$122.16M$130.10M$66.89M$35.63M$53.99M$59.44M
    Short-Term Investments$72.08M$47.50M$176.64M$135.93M$62.88M$50.75M
    Total Current Assets$44.43M$198.66M$180.33M$246.62M$178.31M$122.25M$115.51M
    Net PP&E$36.0K$270.0K$503.0K$339.0K$243.0K$152.0K
    Goodwill
    Intangibles
    Total Assets$44.43M$230.33M$196.59M$310.13M$238.99M$122.83M$116.01M
    LiabilitiesTotal Current Liabilities$5.15M$7.81M$12.97M$27.61M$30.01M$46.85M
    Short-Term Debt$0$8.77M$19.67M
    Long-Term Debt$0$29.90M$29.42M$22.40M$11.90M
    Long-Term Leases$0$284.0K$150.0K
    Total Liabilities$6.37M$5.15M$7.81M$43.15M$57.18M$52.40M$58.74M
    EquityCommon Stock & APIC$4.0K$4.0K$6.0K$6.0K$6.0K$7.0K
    Retained Earnings-$26.96M-$127.57M-$170.43M-$222.80M-$325.13M-$446.46M-$499.92M
    Total Equity-$18.59M$225.18M$188.78M$266.97M$181.82M$70.43M$57.26M
    HighlightsNet Cash / (Debt)$142.14M$85.70M$78.63M

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating-$7.45M-$17.96M-$35.15M-$43.06M-$86.22M-$115.54M-$91.79M
    Cash from Investing-$104.12M$39.19M-$171.67M$48.03M$133.93M$78.95M
    Cash from Financing$44.67M$200.47M$3.91M$151.75M$6.93M-$34.0K$35.47M
    SummaryCapital Expenditure-$40.0K-$161.0K-$21.0K-$16.0K-$88.0K$0
    Free Cash Flow-$18.00M-$35.31M-$43.09M-$86.23M-$115.63M-$91.79M
    FCF Margin

    Ratios